{
  "docId": "019de076-f978-76c3-9c95-6b6ce7102162",
  "docSlug": "c02a1d1cb7557bc430cc8dc61cd27097",
  "documentTitle": "CG Oncology | IPO Presentation Deck | 45 slides",
  "authorId": "cg-oncology",
  "authorName": "CG Oncology",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2024-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7761332,
  "pageNumber": 45,
  "pageCount": 45,
  "prevPage": 44,
  "nextPage": null,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide uses a structured table format to categorize achievements into three pillars: Clinical, Corporate, and Financing.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-f978-76c3-9c95-6b6ce7102162/45",
  "deckHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162",
  "deckJsonHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162.json",
  "deckAnchorHref": "/decks/019de076-f978-76c3-9c95-6b6ce7102162#slide-45",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.14,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "callout",
      "text": "At a Glance",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1691758-ae09-4384-a5f7-3f93a0124cad",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.92,
        "x": 0.05,
        "y": 0.3
      },
      "kind": "list",
      "text": "Clinical: Completed enrollment ahead of schedule in Phase 3 Cretostimogene monotherapy trial in BCG-unresponsive NMIBC (BOND-003) with topline monotherapy data released at SUO Conference in Dec 2023; Announcement of positive topline Phase 2 Cretostimogene combo data in BCG-unresponsive NMIBC (CORE-001) in May 2023",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a3cba69e-5a46-45cd-867c-95d440414519",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.05,
        "y": 0.58
      },
      "kind": "list",
      "text": "Corporate: New additions to our Executive Leadership Team and Senior Leadership Team to develop and commercialize Cretostimogene to be the backbone therapy for NMIBC",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e937b84e-3478-459a-b9ba-88012c66c2e4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.92,
        "x": 0.05,
        "y": 0.78
      },
      "kind": "list",
      "text": "Financing: Raised $225M led by quality Life Sciences-focused investors including ABG, Acorn Bioventures, Avidity Partners, BVF, Decheng Capital, Foresite Capital, Janus Henderson, Longitude Venture Partners, ORI Capital, RA Capital and TCG Crossover",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb004401-0f56-44b5-8a77-9158453e9271",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.75,
        "x": 0.19,
        "y": 0.03
      },
      "kind": "title",
      "text": "CG Oncology is Meaningfully Positioned to Become the Leading Company in Bladder Cancer",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a006849e-1b04-4add-95ad-0fbb206a5707",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.74,
        "x": 0.23,
        "y": 0.19
      },
      "kind": "title",
      "text": "Key Value Creation Since 2022",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "233c6475-6dee-4f14-bd5f-f0605fa9a34d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "328ac865-deb6-4175-ae7e-0ebfc05c7c0d",
      "evidence": "The slide is titled 'CG Oncology is Meaningfully Positioned to Become the Leading Company in Bladder Cancer' and includes a section titled 'At a Glance'.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}